12th Annual EUROHNC: the current management of head & neck cancer within a multidisciplinary framework Events, Seminars, & Publications 15. 10. 2019 The 12th Annual European Head and Neck Course was held in Amsterdam, from 9-11 October 2019 and brought together faculty members from many of the leading head and neck cancer centers from Europe and North America. The Greek delegates, Professor Ourania Nicolatou-Galitis, Professor Ioannis Sengas, Professor Timos Kyrodimos, Miltiades Trichas, Radiation Oncologist, and Vasilis Bakas, ENT Physician, all members of the Hellenic Society of Head and Neck Cancer, were happy to attend and participate in the Cours. www.eurohnc.com The experience of the faculty created a stimulating atmosphere. The excellent program covered the majority of the multidisciplinary approach, as it is needed, especially in head and neck cancer. The recent advances in diagnosis and treatment were provided with lectures and videos. Carcinogenesis, photodynamic therapy, transoral robotic surgery, function sparing radiotherapy, oropharyngeal cancers, including HPV related, were some of the main topics of the meeting. The Greek Delegation was awarded the 3rd Prize for their participation and presentation and wishes to thank the Organizers for the honor, as well as for the warm hospitality, and for offering this excellent course, which provided exceptionally high standards of education to all participants. Tags: head and neck cancer , radiotherapy , HPV , mouth cancer
Conference of the Hellenic Society of Head and Neck Cancer Events, Seminars, & Publications 18. 11. 2025 The Conference of the Hellenic Society of Head and Neck Cancer took place on 7–8 November 2025 at LAED in Athens with outstanding success, high participation, and a rich scientific program.The high q...[Read more]
Strength Through Community – Join Today! Quality of Life 11. 07. 2025 Two Communities, One Purpose: Support, Sharing, and Empowerment in Facing CancerCancer is not just a medical challenge. It is a deeply human experience that affects both patients and healthcare profes...[Read more]
How likely are you to develop osteonecrosis of the jaw? Quality of Life 27. 06. 2025 Antiresorptive drugs help with osteoporosis and reduce bone complications in cancer patients, but they may cause osteonecrosis of the jaw (ONJ).Are you in the high-risk group?...[Read more]